{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T12:10:15Z","timestamp":1790251815578,"version":"4.1.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T00:00:00Z","timestamp":1785369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T00:00:00Z","timestamp":1785369600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100010878","name":"AbbVie Inc. | AbbVie Biotherapeutics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010878","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1038\/s41375-026-03049-3","type":"journal-article","created":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T07:16:27Z","timestamp":1785395787000},"page":"2283-2297","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Breast implant associated anaplastic large cell lymphoma is a heterogeneous T cell disease with active pro-tumour cross-talk and immune suppression"],"prefix":"10.1038","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2257-6388","authenticated-orcid":false,"given":"C.","family":"D\u2019Souza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niko","family":"Thio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-4386-1327","authenticated-orcid":false,"given":"Ruiqing","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harini","family":"DeSilva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Mempin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciano","family":"Martelotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Semple","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5206-5111","authenticated-orcid":false,"given":"Ella","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Lade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5777-8284","authenticated-orcid":false,"given":"Mark","family":"Magnusson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Houseman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Overstall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Thorne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anand","family":"Deva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carrie","family":"van der Weyden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9902-0022","authenticated-orcid":false,"given":"Piers","family":"Blombery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0058-2448","authenticated-orcid":false,"given":"H. Miles","family":"Prince","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2729-5887","authenticated-orcid":false,"given":"Paul J.","family":"Neeson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,30]]},"reference":[{"key":"3049_CR1","doi-asserted-by":"publisher","first-page":"169","DOI":"10.21037\/gs.2016.11.03","volume":"6","author":"MW Clemens","year":"2017","unstructured":"Clemens MW, Nava MB, Rocco N, Miranda RN. Understanding rare adverse sequelae of breast implants: anaplastic large-cell lymphoma, late seromas, and double capsules. Gland Surg. 2017;6:169\u201384.","journal-title":"Gland Surg"},{"key":"3049_CR2","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1097\/PRS.0000000000003282","volume":"139","author":"EL Doren","year":"2017","unstructured":"Doren EL, Miranda RN, Selber JC, Garvey PB, Liu J, Medeiros LJ, et al. U.S. Epidemiology of Breast Implant-Associated Anaplastic Large Cell Lymphoma. Plast Reconstr Surg. 2017;139:1042\u201350.","journal-title":"Plast Reconstr Surg"},{"key":"3049_CR3","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1097\/PRS.0000000000003654","volume":"140","author":"A Loch-Wilkinson","year":"2017","unstructured":"Loch-Wilkinson A, Beath KJ, Knight RJW, Wessels WLF, Magnusson M, Papadopoulos T, et al. Breast Implant-Associated Anaplastic Large Cell Lymphoma in Australia and New Zealand: High-Surface-Area Textured Implants Are Associated with Increased Risk. Plast Reconstr Surg. 2017;140:645\u201354.","journal-title":"Plast Reconstr Surg"},{"key":"3049_CR4","doi-asserted-by":"crossref","unstructured":"Deva AK, Turner SD, Kadin ME, Magnusson MR, Prince HM, Miranda RN, et al. Etiology of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL): Current Directions in Research. Cancers. 2020;12:3861.","DOI":"10.3390\/cancers12123861"},{"key":"3049_CR5","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1200\/JCO.2013.52.7911","volume":"32","author":"RN Miranda","year":"2014","unstructured":"Miranda RN, Aladily TN, Prince HM, Kanagal-Shamanna R, de Jong D, Fayad LE, et al. Breast implant-associated anaplastic large-cell lymphoma: long-term follow-up of 60 patients. J Clin Oncol. 2014;32:114\u201320.","journal-title":"J Clin Oncol"},{"key":"3049_CR6","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1093\/asj\/sjy331","volume":"39","author":"MW Clemens","year":"2019","unstructured":"Clemens MW, Jacobsen ED, Horwitz SM. 2019 NCCN Consensus Guidelines on the Diagnosis and Treatment of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL). Aesthet Surg J. 2019;39:S3\u2013s13.","journal-title":"Aesthet Surg J"},{"key":"3049_CR7","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1097\/PRS.0000000000011370","volume":"154","author":"MW Clemens","year":"2024","unstructured":"Clemens MW, Myckatyn TM, Di Napoli A, Feldman AL, Jaffe ES, Haymaker CL, et al. American Association of Plastic Surgeons Consensus on Breast Implant-Associated Anaplastic Large-Cell Lymphoma. Plast Reconstr Surg. 2024;154:473\u201383.","journal-title":"Plast Reconstr Surg"},{"key":"3049_CR8","doi-asserted-by":"publisher","first-page":"e387","DOI":"10.3324\/haematol.2016.146118","volume":"101","author":"P Blombery","year":"2016","unstructured":"Blombery P, Thompson ER, Jones K, Arnau GM, Lade S, Markham JF, et al. Whole exome sequencing reveals activating JAK1 and STAT3 mutations in breast implant-associated anaplastic large cell lymphoma anaplastic large cell lymphoma. Haematologica. 2016;101:e387\u201390.","journal-title":"Haematologica"},{"key":"3049_CR9","doi-asserted-by":"publisher","first-page":"59s","DOI":"10.1097\/PRS.0000000000005570","volume":"143","author":"P Blombery","year":"2019","unstructured":"Blombery P, Thompson ER, Prince HM. Molecular Drivers of Breast Implant-Associated Anaplastic Large Cell Lymphoma. Plast Reconstr Surg. 2019;143:59s\u201364s.","journal-title":"Plast Reconstr Surg"},{"key":"3049_CR10","doi-asserted-by":"publisher","first-page":"30e","DOI":"10.1097\/PRS.0000000000007423","volume":"147","author":"RC DeCoster","year":"2021","unstructured":"DeCoster RC, Clemens MW, Di Napoli A, Lynch EB, Bonaroti AR, Rinker BD, et al. Cellular and Molecular Mechanisms of Breast Implant-Associated Anaplastic Large Cell Lymphoma. Plast Reconstr Surg. 2021;147:30e\u201341e.","journal-title":"Plast Reconstr Surg"},{"key":"3049_CR11","doi-asserted-by":"publisher","first-page":"S21","DOI":"10.1093\/asj\/sjy229","volume":"39","author":"SD Turner","year":"2019","unstructured":"Turner SD. The Cellular Origins of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL): Implications for Immunogenesis. Aesthet Surg J. 2019;39:S21\u2013S7.","journal-title":"Aesthet Surg J"},{"key":"3049_CR12","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1097\/PRS.0000000000002010","volume":"137","author":"H Hu","year":"2016","unstructured":"Hu H, Johani K, Almatroudi A, Vickery K, Van Natta B, Kadin ME, et al. Bacterial Biofilm Infection Detected in Breast Implant-Associated Anaplastic Large-Cell Lymphoma. Plast Reconstr Surg. 2016;137:1659\u201369.","journal-title":"Plast Reconstr Surg"},{"key":"3049_CR13","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.3390\/ma11122393","volume":"11","author":"M Mempin","year":"2018","unstructured":"Mempin M, Hu H, Chowdhury D, Deva A, Vickery K. The A, B and C\u2019s of Silicone Breast Implants: Anaplastic Large Cell Lymphoma, Biofilm and Capsular Contracture. Materials. 2018;11:2393.","journal-title":"Materials"},{"key":"3049_CR14","doi-asserted-by":"crossref","unstructured":"Mempin M, Hu H, Vickery K, Kadin ME, Prince HM, Kouttab N, et al. Gram-Negative Bacterial Lipopolysaccharide Promotes Tumor Cell Proliferation in Breast Implant-Associated Anaplastic Large-Cell Lymphoma. Cancers. 2021;13:5298.","DOI":"10.3390\/cancers13215298"},{"key":"3049_CR15","doi-asserted-by":"crossref","unstructured":"Rogges E, Bertolazzi G, Vacca D, Borro M, Lopez G, Simmaco M, et al. High-Throughput Molecular Characterization of the Microbiome in Breast Implant-Associated Anaplastic Large Cell Lymphoma and Peri-Implant Benign Seromas. Cancers. 2025;17:3839.","DOI":"10.3390\/cancers17233839"},{"key":"3049_CR16","doi-asserted-by":"publisher","first-page":"e63","DOI":"10.1016\/j.clbc.2020.06.011","volume":"21","author":"SL Goff","year":"2021","unstructured":"Goff SL, Danforth DN. The Role of Immune Cells in Breast Tissue and Immunotherapy for the Treatment of Breast Cancer. Clinical Breast Cancer. 2021;21:e63\u2013e73.","journal-title":"Clinical Breast Cancer"},{"key":"3049_CR17","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1038\/s41591-018-0078-7","volume":"24","author":"P Savas","year":"2018","unstructured":"Savas P, Virassamy B, Ye C, Salim A, Mintoff CP, Caramia F, et al. Single-cell profiling of breast cancer T cells reveals a tissue-resident memory subset associated with improved prognosis. Nat Med. 2018;24:986\u201393.","journal-title":"Nat Med"},{"key":"3049_CR18","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.ajpath.2019.09.005","volume":"190","author":"SD Turner","year":"2020","unstructured":"Turner SD, Inghirami G, Miranda RN, Kadin ME. Cell of Origin and Immunologic Events in the Pathogenesis of Breast Implant-Associated Anaplastic Large-Cell Lymphoma. Am J Pathol. 2020;190:2\u201310.","journal-title":"Am J Pathol"},{"key":"3049_CR19","doi-asserted-by":"publisher","first-page":"2156","DOI":"10.1182\/blood-2006-06-028969","volume":"109","author":"L Lamant","year":"2007","unstructured":"Lamant L, de Reynies A, Duplantier MM, Rickman DS, Sabourdy F, Giuriato S, et al. Gene-expression profiling of systemic anaplastic large-cell lymphoma reveals differences based on ALK status and two distinct morphologic ALK+ subtypes. Blood. 2007;109:2156\u201364.","journal-title":"Blood"},{"key":"3049_CR20","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.3324\/haematol.2019.245860","volume":"106","author":"N Oishi","year":"2021","unstructured":"Oishi N, Hundal T, Phillips JL, Dasari S, Hu G, Viswanatha DS, et al. Molecular profiling reveals a hypoxia signature in breast implant-associated anaplastic large cell lymphoma. Haematologica. 2021;106:1714\u201324.","journal-title":"Haematologica"},{"key":"3049_CR21","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/s41379-018-0130-7","volume":"32","author":"A Di Napoli","year":"2019","unstructured":"Di Napoli A, De Cecco L, Piccaluga PP, Navari M, Cancila V, Cippitelli C, et al. Transcriptional analysis distinguishes breast implant-associated anaplastic large cell lymphoma from other peripheral T-cell lymphomas. Mod Pathol. 2019;32:216\u201330.","journal-title":"Mod Pathol"},{"key":"3049_CR22","doi-asserted-by":"crossref","unstructured":"Di Napoli A, Vacca D, Bertolazzi G, Lopez G, Piane M, Germani A, et al. RNA Sequencing of Primary Cutaneous and Breast-Implant Associated Anaplastic Large Cell Lymphomas Reveals Infrequent Fusion Transcripts and Upregulation of PI3K\/AKT Signaling via Neurotrophin Pathway Genes. Cancers. 2021;13:6174.","DOI":"10.3390\/cancers13246174"},{"key":"3049_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-021-01419-2","volume":"20","author":"K Rindler","year":"2021","unstructured":"Rindler K, Jonak C, Alkon N, Thaler FM, Kurz H, Shaw LE, et al. Single-cell RNA sequencing reveals markers of disease progression in primary cutaneous T-cell lymphoma. Mol Cancer. 2021;20:124.","journal-title":"Mol Cancer"},{"key":"3049_CR24","doi-asserted-by":"publisher","first-page":"2610","DOI":"10.1158\/1078-0432.CCR-21-4437","volume":"28","author":"AM Gaydosik","year":"2022","unstructured":"Gaydosik AM, Stonesifer CJ, Khaleel AE, Geskin LJ, Fuschiotti P. Single-Cell RNA Sequencing Unveils the Clonal and Transcriptional Landscape of Cutaneous T-Cell Lymphomas. Clin Cancer Res. 2022;28:2610\u201322.","journal-title":"Clin Cancer Res"},{"key":"3049_CR25","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.cell.2018.11.043","volume":"176","author":"H Li","year":"2019","unstructured":"Li H, van der Leun AM, Yofe I, Lubling Y, Gelbard-Solodkin D, van Akkooi ACJ, et al. Dysfunctional CD8 T Cells Form a Proliferative, Dynamically Regulated Compartment within Human Melanoma. Cell. 2019;176:775\u201389.e18.","journal-title":"Cell"},{"key":"3049_CR26","doi-asserted-by":"crossref","unstructured":"Kadin ME, Morgan J, Xu H, Epstein AL, Sieber D, Hubbard BA, et al. IL-13 is produced by tumor cells in Breast Implant Associated Anaplastic Large Cell Lymphoma: implications for pathogenesis. Hum Pathol. 2018;78:54-62.","DOI":"10.1016\/j.humpath.2018.04.007"},{"key":"3049_CR27","doi-asserted-by":"publisher","first-page":"E312","DOI":"10.1002\/ajh.27055","volume":"98","author":"H Hu","year":"2023","unstructured":"Hu H, Shklovskaya E, Deva A, Xu H, Fan K, Brosamer K, et al. Diagnosis of breast implant associated anaplastic large cell lymphoma by analysis of cytokines in peri-implant seromas. Am J Hematol. 2023;98:E312\u2013E4.","journal-title":"Am J Hematol"},{"key":"3049_CR28","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1038\/s41416-024-02881-7","volume":"131","author":"M Villa","year":"2024","unstructured":"Villa M, Sharma GG, Malighetti F, Mauri M, Arosio G, Cordani N, et al. Recurrent somatic mutations of FAT family cadherins induce an aggressive phenotype and poor prognosis in anaplastic large cell lymphoma. Br J Cancer. 2024;131:1781\u201395.","journal-title":"Br J Cancer"},{"key":"3049_CR29","doi-asserted-by":"publisher","first-page":"2821","DOI":"10.1182\/blood-2015-07-658823","volume":"126","author":"L Dai","year":"2015","unstructured":"Dai L, Trillo-Tinoco J, Cao Y, Bonstaff K, Doyle L, Del Valle L, et al. Targeting HGF\/c-MET induces cell cycle arrest, DNA damage, and apoptosis for primary effusion lymphoma. Blood. 2015;126:2821\u201331.","journal-title":"Blood"},{"key":"3049_CR30","doi-asserted-by":"publisher","first-page":"597468","DOI":"10.3389\/fonc.2020.597468","volume":"10","author":"L Liu","year":"2020","unstructured":"Liu L, Wang L, Zhao L, He C, Wang G. The Role of HLA-G in Tumor Escape: Manipulating the Phenotype and Function of Immune Cells. Front Oncol. 2020;10:597468.","journal-title":"Front Oncol"},{"key":"3049_CR31","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1038\/s41388-023-02593-x","volume":"42","author":"ZC Nwosu","year":"2023","unstructured":"Nwosu ZC, Song MG, di Magliano MP, Lyssiotis CA, Kim SE. Nutrient transporters: connecting cancer metabolism to therapeutic opportunities. Oncogene. 2023;42:711\u201324.","journal-title":"Oncogene"},{"key":"3049_CR32","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1097\/SLA.0000000000004179","volume":"272","author":"JA Nelson","year":"2020","unstructured":"Nelson JA, Dabic S, Mehrara BJ, Cordeiro PG, Disa JJ, Pusic AL, et al. Breast Implant-associated Anaplastic Large Cell Lymphoma Incidence: Determining an Accurate Risk. Ann Surg. 2020;272:403\u20139.","journal-title":"Ann Surg"},{"key":"3049_CR33","doi-asserted-by":"publisher","first-page":"e3499","DOI":"10.1097\/GOX.0000000000003499","volume":"9","author":"E Matros","year":"2021","unstructured":"Matros E, Shamsunder MG, Rubenstein RN, Polanco TO, McCarthy CM, Nelson JA, et al. Textured and Smooth Implant Use Reported in the Tracking Operations and Outcomes for Plastic Surgeons Database: Epidemiologic Implications for BIA-ALCL. Plast Reconstr Surg Glob Open. 2021;9:e3499.","journal-title":"Plast Reconstr Surg Glob Open"},{"key":"3049_CR34","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1200\/JCO.2015.63.3412","volume":"34","author":"MW Clemens","year":"2016","unstructured":"Clemens MW, Medeiros LJ, Butler CE, Hunt KK, Fanale MA, Horwitz S, et al. Complete Surgical Excision Is Essential for the Management of Patients With Breast Implant-Associated Anaplastic Large-Cell Lymphoma. J Clin Oncol. 2016;34:160\u20138.","journal-title":"J Clin Oncol"},{"key":"3049_CR35","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1007\/s00262-020-02778-3","volume":"70","author":"A Di Napoli","year":"2021","unstructured":"Di Napoli A, Greco D, Scafetta G, Ascenzi F, Gulino A, Aurisicchio L, et al. IL-10, IL-13, Eotaxin and IL-10\/IL-6 ratio distinguish breast implant-associated anaplastic large-cell lymphoma from all types of benign late seromas. Cancer Immunol Immunother. 2021;70:1379\u201392.","journal-title":"Cancer Immunol Immunother"},{"key":"3049_CR36","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1182\/blood.2020009346","volume":"138","author":"A Herrera","year":"2021","unstructured":"Herrera A, Cheng A, Mimitou EP, Seffens A, George D, Bar-Natan M, et al. Multimodal single-cell analysis of cutaneous T-cell lymphoma reveals distinct subclonal tissue-dependent signatures. Blood. 2021;138:1456\u201364.","journal-title":"Blood"},{"key":"3049_CR37","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1093\/asj\/sjw023","volume":"36","author":"ME Kadin","year":"2016","unstructured":"Kadin ME, Deva A, Xu H, Morgan J, Khare P, MacLeod RA, et al. Biomarkers Provide Clues to Early Events in the Pathogenesis of Breast Implant-Associated Anaplastic Large Cell Lymphoma. Aesthet Surg J. 2016;36:773\u201381.","journal-title":"Aesthet Surg J"},{"key":"3049_CR38","doi-asserted-by":"crossref","unstructured":"Fiore D, Cappelli LV, Zumbo P, Phillips JM, Liu Z, Cheng S, et al. A Novel JAK1 Mutant Breast Implant-Associated Anaplastic Large Cell Lymphoma Patient-Derived Xenograft Fostering Pre-Clinical Discoveries. Cancers. 2020;12:1603.","DOI":"10.3390\/cancers12061603"},{"key":"3049_CR39","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1038\/s41375-020-01093-1","volume":"35","author":"C Lobello","year":"2021","unstructured":"Lobello C, Tichy B, Bystry V, Radova L, Filip D, Mraz M, et al. STAT3 and TP53 mutations associate with poor prognosis in anaplastic large cell lymphoma. Leukemia. 2021;35:1500\u20135.","journal-title":"Leukemia"},{"key":"3049_CR40","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1182\/blood.2022017643","volume":"142","author":"JE Brammer","year":"2023","unstructured":"Brammer JE, Ballen K, Sokol L, Querfeld C, Nakamura R, Mishra A, et al. Effective treatment with the selective cytokine inhibitor BNZ-1 reveals the cytokine dependency of T-LGL leukemia. Blood. 2023;142:1271\u201380.","journal-title":"Blood"},{"key":"3049_CR41","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/s41590-022-01127-z","volume":"23","author":"N Jacquelot","year":"2022","unstructured":"Jacquelot N, Seillet C, Vivier E, Belz GT. Innate lymphoid cells and cancer. Nat Immunol. 2022;23:371\u20139.","journal-title":"Nat Immunol"},{"key":"3049_CR42","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1182\/blood.2024027700","volume":"147","author":"AL Feldman","year":"2026","unstructured":"Feldman AL, Dasari S, Rimsza LM, Scott DW, Oishi N, Hu G, et al. Gene expression profiling reveals 2 overarching types of ALCL with distinct targetable biology: an LLMPP study. Blood. 2026;147:1199\u2013214.","journal-title":"Blood"},{"key":"3049_CR43","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1111\/bjh.14431","volume":"180","author":"A Di Napoli","year":"2018","unstructured":"Di Napoli A, Jain P, Duranti E, Margolskee E, Arancio W, Facchetti F, et al. Targeted next generation sequencing of breast implant-associated anaplastic large cell lymphoma reveals mutations in JAK\/STAT signalling pathway genes, TP53 and DNMT3A. Br J Haematol. 2018;180:741\u20134.","journal-title":"Br J Haematol"},{"key":"3049_CR44","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/s00428-018-2352-y","volume":"473","author":"A Letourneau","year":"2018","unstructured":"Letourneau A, Maerevoet M, Milowich D, Dewind R, Bisig B, Missiaglia E, et al. Dual JAK1 and STAT3 mutations in a breast implant-associated anaplastic large cell lymphoma. Virchows Arch. 2018;473:505\u201311.","journal-title":"Virchows Arch"},{"key":"3049_CR45","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1182\/blood-2017-12-821868","volume":"132","author":"N Oishi","year":"2018","unstructured":"Oishi N, Brody GS, Ketterling RP, Viswanatha DS, He R, Dasari S, et al. Genetic subtyping of breast implant-associated anaplastic large cell lymphoma. Blood. 2018;132:544\u20137.","journal-title":"Blood"},{"key":"3049_CR46","first-page":"360","volume":"135","author":"C Laurent","year":"2020","unstructured":"Laurent C, Nicolae A, Laurent C, Le Bras F, Haioun C, Fataccioli V, et al. Gene alterations in epigenetic modifiers and JAK-STAT signaling are frequent in breast implant-associated ALCL. Blood. 2020;135:360\u201370.","journal-title":"Blood"},{"key":"3049_CR47","doi-asserted-by":"publisher","first-page":"2927","DOI":"10.1182\/blood.2020005372","volume":"136","author":"GT Los-de Vries","year":"2020","unstructured":"Los-de Vries GT, de Boer M, van Dijk E, Stathi P, Hijmering NJ, Roemer MGM, et al. Chromosome 20 loss is characteristic of breast implant-associated anaplastic large cell lymphoma. Blood. 2020;136:2927\u201332.","journal-title":"Blood"},{"key":"3049_CR48","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1111\/tbj.14205","volume":"27","author":"AE Quesada","year":"2021","unstructured":"Quesada AE, Zhang Y, Ptashkin R, Ho C, Horwitz S, Benayed R, et al. Next generation sequencing of breast implant-associated anaplastic large cell lymphomas reveals a novel STAT3-JAK2 fusion among other activating genetic alterations within the JAK-STAT pathway. Breast J. 2021;27:314\u201321.","journal-title":"Breast J"},{"key":"3049_CR49","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3324\/haematol.2022.281119","volume":"108","author":"W Grey","year":"2023","unstructured":"Grey W. WT1 \u03b2\u2018ing catenin into shape: a new interaction driving epigenetic plasticity in acute myeloid leukemia? Haematologica. 2023;108:5\u20136.","journal-title":"Haematologica"},{"key":"3049_CR50","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.humpath.2019.05.007","volume":"90","author":"V Tabanelli","year":"2019","unstructured":"Tabanelli V, Corsini C, Fiori S, Agostinelli C, Calleri A, Orecchioni S, et al. Recurrent PDL1 expression and PDL1 (CD274) copy number alterations in breast implant-associated anaplastic large cell lymphomas. Hum Pathol. 2019;90:60\u20139.","journal-title":"Hum Pathol"},{"key":"3049_CR51","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1016\/j.cell.2019.05.031","volume":"177","author":"T Stuart","year":"2019","unstructured":"Stuart T, Butler A, Hoffman P, Hafemeister C, Papalexi E, Mauck WM 3rd, et al. Comprehensive Integration of Single-Cell Data. Cell. 2019;177:1888\u2013902 e21.","journal-title":"Cell"},{"key":"3049_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-35238-w","volume":"14","author":"S Tietscher","year":"2023","unstructured":"Tietscher S, Wagner J, Anzeneder T, Langwieder C, Rees M, Sobottka B, et al. A comprehensive single-cell map of T cell exhaustion-associated immune environments in human breast cancer. Nat Commun. 2023;14:98.","journal-title":"Nat Commun"},{"key":"3049_CR53","doi-asserted-by":"publisher","first-page":"3796","DOI":"10.1016\/j.csbj.2021.06.043","volume":"19","author":"M Andreatta","year":"2021","unstructured":"Andreatta M, Carmona SJ. UCell: Robust and scalable single-cell gene signature scoring. Comput Struct Biotechnol J. 2021;19:3796\u20138.","journal-title":"Comput Struct Biotechnol J"},{"key":"3049_CR54","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/s41596-024-01045-4","volume":"20","author":"S Jin","year":"2025","unstructured":"Jin S, Plikus MV, Nie Q. CellChat for systematic analysis of cell\u2013cell communication from single-cell transcriptomics. Nature Protocols. 2025;20:180\u2013219.","journal-title":"Nature Protocols"},{"key":"3049_CR55","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1038\/s41596-020-0292-x","volume":"15","author":"M Efremova","year":"2020","unstructured":"Efremova M, Vento-Tormo M, Teichmann SA, Vento-Tormo R. CellPhoneDB: inferring cell\u2013cell communication from combined expression of multi-subunit ligand\u2013receptor complexes. Nature Protocols. 2020;15:1484\u2013506.","journal-title":"Nature Protocols"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41375-026-03049-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-026-03049-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-026-03049-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T11:43:20Z","timestamp":1790250200000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41375-026-03049-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,30]]},"references-count":55,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["3049"],"URL":"https:\/\/doi.org\/10.1038\/s41375-026-03049-3","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,30]]},"assertion":[{"value":"12 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"PJN received research funding from Roche Genentech, BMS, MSD, Compugen, Beigene and CRISPR Therapeutics. HMP received research funding from AbbVie for this study. The authors have no other conflicts of interest to declare.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"This study was approved by Peter MacCallum Cancer Centre human ethics committee (Reference no. 44068) and by Macquarie University human ethics committee (Reference No. 5201600427). Informed consent was obtained from all participating patients in this cohort study. All methods were performed in accordance with the approved ethics guidelines and regulations.","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Ethics"}}]}}